Printer Friendly

UNIMED REPORTS SECOND QUARTER RESULTS

 UNIMED REPORTS SECOND QUARTER RESULTS
 SOMERVILLE, N.J., May 19 /PRNewswire/ -- UNIMED, Inc. (NASDAQ: UMED)


reported total consolidated revenues for the second quarter of the fiscal year ended March 31, of $1,801,000, $506,000 or 39 percent greater than consolidated revenues of $1,295,000 for the second quarter of fiscal 1991. The company reported a net loss of $444,000 or 9 cents per share for the fiscal quarter, as compared to a net loss of $343,000 or 10 cents per share for the fiscal 1991 quarter.
 Total consolidated revenues of the company for the six months ended March 31, 1992, of $3,565,000 were $1,065,000 or 43 percent greater than consolidated revenues of $2,500,000 for the six months ended March 31, 1991. The company reported a net loss of $887,000 or 19 cents per share for the fiscal 1992 period as compared to a net loss of $621,000 or 19 cents per share for the fiscal 1991 period.
 Commenting on the company's performance, David E. Riggs, chief financial officer, said, "We are making progress in the transition of UNIMED from its traditional focus on research and development to a company with an emphasis on sales and marketing. During the quarter, we acquired two new products for introduction through our sales force and from the exercise of outstanding warrants substantially strengthened our balance sheet."
 UNIMED, Inc. specializes in the development and marketing of pharmaceuticals, with emphasis on therapy and supportive care of cancer patients and AIDS patients.
 UNIMED INC. AND SUBSIDIARIES
 Summary of Financial Information
 Periods ended March 31 Three months Six months
 Income Statement 1992 1991 1992 1991
 Total revenues $1,801,000 $1,295,000 $3,565,000 $2,500,000
 Net loss $ (444,000) $ (343,000) $ (887,000) $ (621,000)
 Net loss per share $ (.09) $ (.10) $ (.19) $ (.19)
 -0- 5/19/92
 /CONTACT: David E. Riggs of UNIMED, 908-526-6894/
 (UMED) CO: Unimed, Inc. ST: New Jersey IN: MTC SU: ERN


PS-LR -- NY083 -- 2006 05/19/92 16:15 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:May 19, 1992
Words:343
Previous Article:THE BOARD OF DIRECTORS OF FIRST BANCORP DECLARES DIVIDEND
Next Article:APPLIED SPECTRUM TECHNOLOGIES REPORTS SECOND-QUARTER RESULTS
Topics:


Related Articles
UNIMED REPORTS RECORD SALES OF MARINOL IN FISCAL YEAR RESULTS
UNIMED REPORTS REVENUE GROWTH OF 46 PERCENT IN FISCAL FIRST QUARTER
UNIMED PHARMACEUTICALS 3RD-QTR SALES UP 27 PERCENT OVER YEAR AGO, E.P.S. $.05
UNIMED REPORTS HIGHER SALES, EARNINGS COMPARED WITH LOSS FOR FIRST QUARTER
UNIMED REPORTS NET INCOME COMPARED WITH LOSS FOR SECOND QUARTER, SIX MONTHS; CASH BALANCES GROW DESPITE RECENT EQUITY INVESTMENT
Unimed Pharmaceuticals Reports Higher Revenues And Earnings For Second Quarter, Six Months
Unimed Pharmaceuticals Reports Higher Revenues in First Quarter
Unimed Pharmaceuticals Reports 41% Revenue Gain in Third Quarter
Unimed Elaborates on Previously Announced Fourth Quarter Loss
Unimed Announces 96% Revenue Growth for First Half of 1998

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters